Casdin Partners Master Fund, L.P. Standard Biotools Inc. (LAB) insider trading activity

Casdin Partners Master Fund, L.P. is Director of STANDARD BIOTOOLS INC.. Currently has a direct ownership of 2.81 Million shares of LAB, which is worth approximately $3.26 Million. The most recent transaction as insider was on Feb 28, 2025, when has been sold 58,215 shares (Common Stock) at a price of $1.06 per share, resulting in proceeds of $61,707. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.81M

75.59% 3M change

75.59% 12M change

Total Value Held $3.26 Million

Casdin Partners Master Fund, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 28 2025	BUY Grant, award, or other acquisition	$61,707 $1.06 p/Share	58,215 Added 2.03%	2,806,470 Common Stock
Mar 05 2024	BUY Open market or private purchase	$3,675 $2.62 p/Share	1,403 Added 0.01%	11,497,928 Common Stock
Mar 04 2024	BUY Open market or private purchase	$642,500 $2.57 p/Share	250,000 Added 2.13%	11,496,525 Common Stock
Jan 05 2024	BUY Grant, award, or other acquisition	-	11,246,525 Added 50.0%	11,246,525 Common Stock

Also insider at

BLFS

BIOLIFE SOLUTIONS INC Healthcare

> 10% Shareholder

DBTX

Decibel Therapeutics, Inc. Healthcare

> 10% Shareholder

VERV

Verve Therapeutics, Inc. Healthcare

> 10% Shareholder

ABSI

Absci Corp Healthcare

Director

MXCT

MAXCYTE, INC. Healthcare

> 10% Shareholder

TNYA

Tenaya Therapeutics, Inc. Healthcare

> 10% Shareholder

CPM